Drug Approval | September 15, 2023
Strides receives tentative USFDA approval for Dolutegravir tablets
The products will be manufactured at the company's facility in Bengaluru
The products will be manufactured at the company's facility in Bengaluru
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
The products will be manufactured at the company's facility in Bengaluru
This approval has come from the company's finished dosage form manufacturing facility
Erythromycin tablets is used to prevent and treat infections in many different parts of the body
The approval bolsters the company's Mycophenolate Mofetil portfolio
Pirfenidone Capsules had estimated annual sales of USD 95 million in the US
Prasugrel tablets are indicated to reduce the rate of thrombotic CV events
This product will be manufactured at Lupin's Pithampur facility in India
Zinc Sulfate Injection is indicated in adult and paediatric patients as a source of zinc for parenteral nutrition
Subscribe To Our Newsletter & Stay Updated
